Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials.
Saved in:
| Title: | Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials. |
|---|---|
| Authors: | Strand V; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA., Schulze-Koops H; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany., Al-Emadi S; Hamad Medical Corporation, Doha, Qatar., Kinch CD; Pfizer Canada ULC, Kirkland, Quebec, Canada kinch.cassandra.d@gmail.com., Gruben D; Pfizer Inc, Groton, Connecticut, USA., Germino R; Pfizer Inc, New York, New York, USA., Connell CA; Pfizer Inc, Groton, Connecticut, USA., Mysler E; Rheumatology, Organización Médica de Investigación, Buenos Aires, Argentina. |
| Source: | BMJ open [BMJ Open] 2025 Dec 24; Vol. 15 (12), pp. e082366. Date of Electronic Publication: 2025 Dec 24. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
